(PRWEB) April 25, 2005
Biogenic Nutraceuticals has announced that it has been appointed as the exclusive, licensed, international distributor for the products of Berean Development, Inc., an emerging biotechnology company focusing on the development and commercialization of naturally occurring compounds for the treatment of Diabetes, Lupus, Fibromyalgia, Arthritis and Cancer. BereanÂs main patented, non-presciption products are MiracÂ®, for lupus, rheumatoid arthritis, fibromyalgia, and certain types of cancer; and AllbaidÂ® for diabetes.
Science driven MiracÂ® is a specially designed, naturally occurringÂ setÂ of regulatory molecules proven effective for lupus, arthritis, fibromyalgia, and some forms of cancer. MiracÂ® is a safe, non-toxic bioflavonoid complex whose mechanism of activity targets the blocking of ion channels in certain lymphocytes. Lupus is caused by Natural KillerÂ (NK) CD4-- and CD8-- T-Lymphocytes, also called T-cells. These T-cells multiply using a potassium gene channel. These same cells cause diabetes. By blocking these ion channels, MiracÂ® prevents the cascade of events leading to inflammatory responses seen in autoimmune and neuroinflammatory type diseases such as lupus.
The efficacy of each of these products is well supported by highly qualified doctors, scientific research, and actual clinical and/or blood tests. Both MiracÂ® and AllbaidÂ® have been approved under the Dietary Supplements Health Education Act of 1994 (ÂDSHEAÂ) as being safe and free of side effects with one exception: people with an allergic reaction to pineapple cannot take Mirac.
Physicians working in the field of Rheumatology, or with diseases of the autoimmune system, or individuals suffering from an inflammatory disease such as lupus, rheumatoid arthritis, fibromyalgia; some forms of cancer; or diabetes; should seriously consider these ground-breaking products.
# # #